Astha Consultancy, Inc - Comment

Document ID: FDA-2011-D-0239-0007
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: August 08 2011, at 12:00 AM Eastern Daylight Time
Date Posted: September 22 2011, at 12:00 AM Eastern Standard Time
Comment Start Date: July 26 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: September 26 2011, at 11:59 PM Eastern Standard Time
Tracking Number: 80eda08f
View Document:  View as format xml

View Comment

We are minority, women-owned small business in the drug discovery and research field since 2006. We collaborate and/or provide computational chemistry & molecular modeling support for developing highly predictive QSAR / QSTR models for efficacy / toxicity predictions based on technologies, such as chemical functions (pharmacophore / toxicophore), molecular fields (CoMFA, CoMSIA), physicochemical properties (2D, 3D) in conjunction with our niche ‘BioActive Conformation Mining Methodology’ (BACM). We have experience working with federal agency (DoD) research laboratories (WRAIR, USAMRICD). We would highly appreciate working for FDA developing predictive and mechanistically insightful QSTR models for toxicity predictions and insights into mechanism of toxicity.

Attachments:

Astha Consultancy, Inc - Comment, Astha_Brochure

Title:
Astha Consultancy, Inc - Comment, Astha_Brochure

View Attachment: View as format msw12 View as format pdf

Related Comments

    View All
Total: 8
Anonymous - Comment
Public Submission    Posted: 09/22/2011     ID: FDA-2011-D-0239-0003

Sep 26,2011 11:59 PM ET
Astha Consultancy, Inc - Comment
Public Submission    Posted: 09/22/2011     ID: FDA-2011-D-0239-0007

Sep 26,2011 11:59 PM ET
ILSI Health and Environmental Sciences Institute (HESI) - Comment
Public Submission    Posted: 09/22/2011     ID: FDA-2011-D-0239-0009

Sep 26,2011 11:59 PM ET
IQ Consortium - Comment
Public Submission    Posted: 10/11/2011     ID: FDA-2011-D-0239-0010

Sep 26,2011 11:59 PM ET
Biotechnology Industry Organization (BIO) - Comment
Public Submission    Posted: 10/11/2011     ID: FDA-2011-D-0239-0012

Sep 26,2011 11:59 PM ET